Divalproex Sodium DR is a Oral Tablet, Delayed Release in the Human Prescription Drug category. It is labeled and distributed by Rebel Distributors Corp. The primary component is Divalproex Sodium.
Product ID | 21695-819_9b3db659-f64c-4c48-946a-6b4f1d800eba |
NDC | 21695-819 |
Product Type | Human Prescription Drug |
Proprietary Name | Divalproex Sodium DR |
Generic Name | Divalproex Sodium |
Dosage Form | Tablet, Delayed Release |
Route of Administration | ORAL |
Marketing Start Date | 2009-10-14 |
Marketing Category | ANDA / ANDA |
Application Number | ANDA078790 |
Labeler Name | Rebel Distributors Corp |
Substance Name | DIVALPROEX SODIUM |
Active Ingredient Strength | 500 mg/1 |
Pharm Classes | Anti-epileptic Agent [EPC],Decreased Central Nervous System Disorganized Electrical Activity [PE],Mood Stabilizer [EPC] |
NDC Exclude Flag | E |
Listing Certified Through | 2017-12-31 |
Marketing Start Date | 2009-10-14 |
NDC Exclude Flag | N |
Sample Package? | N |
Marketing Category | ANDA |
Application Number | ANDA078790 |
Product Type | HUMAN PRESCRIPTION DRUG |
Billing Unit | EA |
Marketing Start Date | 2009-10-14 |
Inactivation Date | 2019-09-24 |
Marketing Category | ANDA |
Application Number | ANDA078790 |
Product Type | HUMAN PRESCRIPTION DRUG |
Billing Unit | EA |
Marketing Start Date | 2009-10-14 |
Inactivation Date | 2019-09-24 |
Ingredient | Strength |
---|---|
DIVALPROEX SODIUM | 500 mg/1 |
SPL SET ID: | 9b3db659-f64c-4c48-946a-6b4f1d800eba |
Manufacturer | |
UNII | |
RxNorm Concept Unique ID - RxCUI |
NDC | Brand Name | Generic Name |
---|---|---|
21695-819 | Divalproex Sodium DR | Divalproex Sodium DR |
21695-817 | Divalproex Sodium DR | Divalproex Sodium DR |
21695-818 | Divalproex Sodium DR | Divalproex Sodium DR |
0074-3826 | Depakote | Divalproex Sodium |
0074-6114 | Depakote | Divalproex Sodium |
0074-6212 | Depakote | Divalproex Sodium |
0074-6214 | Depakote | Divalproex Sodium |
0074-6215 | Depakote | Divalproex Sodium |
0074-7126 | Depakote | Divalproex Sodium |